{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T10:38:18Z","timestamp":1786271898439,"version":"build-2736575974"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,1,26]],"date-time":"2022-01-26T00:00:00Z","timestamp":1643155200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,26]],"date-time":"2022-01-26T00:00:00Z","timestamp":1643155200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100008272","name":"Novartis Pharmaceuticals Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2022,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Telemedicine encompasses a variety of modalities that allow for the remote assessment and treatment of patients. The technologies, services, and tools available for telemedicine in the USA are increasingly becoming an integral part of the healthcare system to bridge the gaps in care that can arise from geographic and\/or socioeconomic obstacles and provider shortages. Telemedicine can be applied to a spectrum of clinical areas, including rheumatic diseases. Psoriatic arthritis (PsA) is a chronic, inflammatory, multisystem disease with predominately skin and joint manifestations. PsA is often misdiagnosed and\/or undiagnosed, which can lead to worse patient outcomes, including irreversible joint erosion and damage. The difficulties in diagnosing and managing PsA are confounded by the emergence and increased use of telemedicine because of the COVID-19 pandemic. Telemedicine presents the opportunity to increase access to healthcare by rheumatologists and dermatologists to improve training and education regarding PsA and to decrease time attributed to office visits associated with PsA. However, challenges in diagnosing PsA without a thorough in-person physical examination by a trained rheumatologist or dermatologist exist. We provide an overview of the ways telemedicine can be incorporated into clinical care and optimized for patients with PsA; characteristic clinical features of PsA, with a focus on skin and joint signs and symptoms; screening tools to be used in routine clinical care; assessments that can be used to evaluate quality of life, functional ability, and disease activity in PsA; and resources and recommendations for the development of future telemedicine use in rheumatology and dermatology.<jats:table-wrap><jats:table><jats:tbody>\n                    <jats:tr>\n                      <jats:td colspan=\"2\"><jats:bold>Key Points<\/jats:bold>\u2022 <jats:italic>Patients with psoriatic arthritis (PsA) are often misdiagnosed and\/or undiagnosed.<\/jats:italic>\u2022 <jats:italic>Telemedicine can improve access to healthcare by rheumatologists and dermatologists.<\/jats:italic>\u2022 <jats:italic>Telemedicine can be incorporated into clinical care and optimized for managing PsA.<\/jats:italic><\/jats:td>\n                    <\/jats:tr>\n                  <\/jats:tbody><\/jats:table><\/jats:table-wrap><\/jats:p>","DOI":"10.1007\/s10067-022-06077-3","type":"journal-article","created":{"date-parts":[[2022,1,26]],"date-time":"2022-01-26T21:02:31Z","timestamp":1643230951000},"page":"1271-1283","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Telemedicine and psoriatic arthritis: best practices and considerations for dermatologists and rheumatologists"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2927-8618","authenticated-orcid":false,"given":"Alice B.","family":"Gottlieb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7311-7689","authenticated-orcid":false,"given":"Alvin F.","family":"Wells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6514-4353","authenticated-orcid":false,"given":"Joseph F.","family":"Merola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,26]]},"reference":[{"issue":"16","key":"6077_CR1","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1056\/NEJMsr1503323","volume":"377","author":"RV Tuckson","year":"2017","unstructured":"Tuckson RV, Edmunds M, Hodgkins ML (2017) Telehealth. N Engl J Med 377(16):1585\u20131592. https:\/\/doi.org\/10.1056\/NEJMsr1503323","journal-title":"N Engl J Med"},{"issue":"10","key":"6077_CR2","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1111\/j.1445-5994.2012.02931.x","volume":"42","author":"LJ Roberts","year":"2012","unstructured":"Roberts LJ, Lamont EG, Lim I, Sabesan S, Barrett C (2012) Telerheumatology: an idea whose time has come. Intern Med J 42(10):1072\u20131078. https:\/\/doi.org\/10.1111\/j.1445-5994.2012.02931.x","journal-title":"Intern Med J"},{"issue":"5","key":"6077_CR3","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1177\/1357633X20916567","volume":"26","author":"AC Smith","year":"2020","unstructured":"Smith AC, Thomas E, Snoswell CL, Haydon H, Mehrotra A, Clemensen J et al (2020) Telehealth for global emergencies: implications for coronavirus disease 2019 (COVID-19). J Telemed Telecare 26(5):309\u2013313. https:\/\/doi.org\/10.1177\/1357633X20916567","journal-title":"J Telemed Telecare"},{"issue":"4","key":"6077_CR4","first-page":"253","volume":"43","author":"V Teixeira","year":"2018","unstructured":"Teixeira V, Cordeiro I, Goncalves MJ, Fonseca JE, Macieira C (2018) Telerheumatology - breaking barriers to access care in rheumatology. Acta Reumatol Port 43(4):253\u2013255","journal-title":"Acta Reumatol Port"},{"issue":"2","key":"6077_CR5","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1056\/NEJMra1601705","volume":"375","author":"ER Dorsey","year":"2016","unstructured":"Dorsey ER, Topol EJ (2016) State of telehealth. N Engl J Med 375(2):154\u2013161. https:\/\/doi.org\/10.1056\/NEJMra1601705","journal-title":"N Engl J Med"},{"issue":"3","key":"6077_CR6","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s11606-015-3489-x","volume":"31","author":"JM Polinski","year":"2016","unstructured":"Polinski JM, Barker T, Gagliano N, Sussman A, Brennan TA, Shrank WH (2016) Patients\u2019 satisfaction with and preference for telehealth visits. J Gen Intern Med 31(3):269\u2013275. https:\/\/doi.org\/10.1007\/s11606-015-3489-x","journal-title":"J Gen Intern Med"},{"issue":"3","key":"6077_CR7","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1111\/1756-185X.12491","volume":"18","author":"KA Poulsen","year":"2015","unstructured":"Poulsen KA, Millen CM, Lakshman UI, Buttner PG, Roberts LJ (2015) Satisfaction with rural rheumatology telemedicine service. Int J Rheum Dis 18(3):304\u2013314. https:\/\/doi.org\/10.1111\/1756-185X.12491","journal-title":"Int J Rheum Dis"},{"issue":"Suppl 1","key":"6077_CR8","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1177\/1357633X010070S104","volume":"7","author":"P Davis","year":"2001","unstructured":"Davis P, Howard R, Brockway P (2001) Telehealth consultations in rheumatology: cost-effectiveness and user satisfaction. J Telemed Telecare 7(Suppl 1):10\u201311. https:\/\/doi.org\/10.1177\/1357633X010070S104","journal-title":"J Telemed Telecare"},{"issue":"12","key":"6077_CR9","doi-asserted-by":"publisher","first-page":"5087","DOI":"10.1007\/s10067-021-05759-8","volume":"40","author":"SS Kong","year":"2021","unstructured":"Kong SS, Otalora Rojas LA, Ashour A, Robinson M, Hosterman T, Bhanusali N (2021) Ability and willingness to utilize telemedicine among rheumatology patients-a cross-sectional survey. Clin Rheumatol 40(12):5087\u20135093. https:\/\/doi.org\/10.1007\/s10067-021-05759-8","journal-title":"Clin Rheumatol"},{"key":"6077_CR10","unstructured":"Mechanic OJ, Persaud Y, Kimball AB. Telehealth systems. StatPearls. Treasure Island (FL); 2020."},{"key":"6077_CR11","doi-asserted-by":"publisher","unstructured":"Gottlieb A, Merola JF (2019) Psoriatic arthritis for dermatologists. J Dermatolog Treat:1\u201318. https:\/\/doi.org\/10.1080\/09546634.2019.1605142.","DOI":"10.1080\/09546634.2019.1605142"},{"issue":"6","key":"6077_CR12","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.clindermatol.2007.08.004","volume":"25","author":"S Kleinert","year":"2007","unstructured":"Kleinert S, Feuchtenberger M, Kneitz C, Tony HP (2007) Psoriatic arthritis: clinical spectrum and diagnostic procedures. Clin Dermatol 25(6):519\u2013523. https:\/\/doi.org\/10.1016\/j.clindermatol.2007.08.004","journal-title":"Clin Dermatol"},{"key":"6077_CR13","doi-asserted-by":"publisher","unstructured":"Alinaghi F, Calov M, Kristensen LE, Gladman DD, Coates LC, Jullien D, et al. (2019) Prevalence of psoriatic arthritis in patients with psoriasis: a systematic review and meta-analysis of observational and clinical studies. J Am Acad Dermatol 80(1):251\u2013265 e219. https:\/\/doi.org\/10.1016\/j.jaad.2018.06.027.","DOI":"10.1016\/j.jaad.2018.06.027"},{"issue":"5","key":"6077_CR14","first-page":"1167","volume":"34","author":"DD Gladman","year":"2007","unstructured":"Gladman DD, Mease PJ, Strand V, Healy P, Helliwell PS, Fitzgerald O et al (2007) Consensus on a core set of domains for psoriatic arthritis. J Rheumatol 34(5):1167\u20131170","journal-title":"J Rheumatol"},{"issue":"10","key":"6077_CR15","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.3899\/jrheum.160904","volume":"44","author":"AM Orbai","year":"2017","unstructured":"Orbai AM, de Wit M, Mease PJ, Callis Duffin K, Elmamoun M, Tillett W et al (2017) Updating the Psoriatic Arthritis (PsA) core domain set: a report from the PsA workshop at OMERACT 2016. J Rheumatol 44(10):1522\u20131528. https:\/\/doi.org\/10.3899\/jrheum.160904","journal-title":"J Rheumatol"},{"issue":"6","key":"6077_CR16","first-page":"809","volume":"17","author":"DD Gladman","year":"1990","unstructured":"Gladman DD, Stafford-Brady F, Chang CH, Lewandowski K, Russell ML (1990) Longitudinal study of clinical and radiological progression in psoriatic arthritis. J Rheumatol 17(6):809\u2013812","journal-title":"J Rheumatol"},{"issue":"6","key":"6077_CR17","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1136\/annrheumdis-2013-204858","volume":"74","author":"M Haroon","year":"2015","unstructured":"Haroon M, Gallagher P, FitzGerald O (2015) Diagnostic delay of more than 6 months contributes to poor radiographic and functional outcome in psoriatic arthritis. Ann Rheum Dis 74(6):1045\u20131050. https:\/\/doi.org\/10.1136\/annrheumdis-2013-204858","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"6077_CR18","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1093\/rheumatology\/keg217","volume":"42","author":"NJ McHugh","year":"2003","unstructured":"McHugh NJ, Balachrishnan C, Jones SM (2003) Progression of peripheral joint disease in psoriatic arthritis: a 5-yr prospective study. Rheumatology (Oxford) 42(6):778\u2013783. https:\/\/doi.org\/10.1093\/rheumatology\/keg217","journal-title":"Rheumatology (Oxford)"},{"key":"6077_CR19","unstructured":"The Office for Civil Rights. The Department of Health and Human Reources (2021) Notification of enforcement discretion for telehealth remote communications during the COVID-19 nationwide public health emergency. https:\/\/www.hhs.gov\/hipaa\/for-professionals\/special-topics\/emergency-preparedness\/notification-enforcement-discretion-telehealth\/index.html, Accessed November 22, 2021"},{"key":"6077_CR20","unstructured":"American Medical Association (2020) AMA digital health implementation playbook. https:\/\/www.ama-assn.org\/amaone\/ama-digital-health-implementation-playbook Accessed September 1, 2020."},{"issue":"8","key":"6077_CR21","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1016\/j.mayocp.2020.05.026","volume":"95","author":"ER Laskowski","year":"2020","unstructured":"Laskowski ER, Johnson SE, Shelerud RA, Lee JA, Rabatin AE, Driscoll SW et al (2020) The telemedicine musculoskeletal examination. Mayo Clin Proc 95(8):1715\u20131731. https:\/\/doi.org\/10.1016\/j.mayocp.2020.05.026","journal-title":"Mayo Clin Proc"},{"issue":"4S","key":"6077_CR22","first-page":"S205","volume":"23","author":"SE Wahezi","year":"2020","unstructured":"Wahezi SE, Duarte RV, Yerra S, Thomas MA, Pujar B, Sehgal N et al (2020) Telemedicine during COVID-19 and beyond: a practical guide and best practices multidisciplinary approach for the orthopedic and neurologic pain physical examination. Pain Physician 23(4S):S205\u2013S238","journal-title":"Pain Physician"},{"issue":"1","key":"6077_CR23","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/bjd.12290","volume":"169","author":"J Rhodes","year":"2013","unstructured":"Rhodes J, Clay C, Phillips M (2013) The surface area of the hand and the palm for estimating percentage of total body surface area: results of a meta-analysis. Br J Dermatol 169(1):76\u201384. https:\/\/doi.org\/10.1111\/bjd.12290","journal-title":"Br J Dermatol"},{"key":"6077_CR24","doi-asserted-by":"publisher","unstructured":"Sampogna F, Sera F, Mazzotti E, Pasquini P, Picardi A, Abeni D, et al. (2003) Performance of the self-administered psoriasis area and severity index in evaluating clinical and sociodemographic subgroups of patients with psoriasis. Arch Dermatol 139(3):353\u2013358; discussion 357. https:\/\/doi.org\/10.1001\/archderm.139.3.353.","DOI":"10.1001\/archderm.139.3.353"},{"key":"6077_CR25","unstructured":"TytoCare. TytoCare | on demand medical exams. Anytime. Anywhere. https:\/\/www.tytocare.com\/. Accessed September 1, 2020"},{"key":"6077_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.conctc.2019.100399","volume":"15","author":"B Perry","year":"2019","unstructured":"Perry B, Geoghegan C, Lin L, McGuire FH, Nido V, Grabert B et al (2019) Patient preferences for using mobile technologies in clinical trials. Contemp Clin Trials Commun 15:100399. https:\/\/doi.org\/10.1016\/j.conctc.2019.100399","journal-title":"Contemp Clin Trials Commun"},{"issue":"11","key":"6077_CR27","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s11926-020-00958-9","volume":"22","author":"S Bell","year":"2020","unstructured":"Bell S, Merola JF, Webster DE, Pennington SR, Liao W, Ogdie A et al (2020) Aiming for cure and preventive initiatives in psoriatic disease: building synergy at NPF, GRAPPA, and PPACMAN. Curr Rheumatol Rep 22(11):78. https:\/\/doi.org\/10.1007\/s11926-020-00958-9","journal-title":"Curr Rheumatol Rep"},{"key":"6077_CR28","unstructured":"Webster D, Haberman R, Perez-Chada L, Simon S, MacDuffie W, DePhillips M, et al. (2020) Development and preliminary validation of smartphone sensor-based measurement tools for psoriatic arthritis [abstract]. Arthritis Rheumatol 72 (suppl 10)."},{"key":"6077_CR29","unstructured":"Sage Bionetworks (2021) The psorcast study. Predictive forecasts of psoriatic disease from remote, patient-driven measurements. https:\/\/sagebionetworks.org\/research-projects\/the-psorcast-study\/. Accessed September 1, 2020"},{"issue":"6","key":"6077_CR30","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1136\/annrheumdis-2014-205207","volume":"73","author":"L Gossec","year":"2014","unstructured":"Gossec L, de Wit M, Kiltz U, Braun J, Kalyoncu U, Scrivo R et al (2014) A patient-derived and patient-reported outcome measure for assessing psoriatic arthritis: elaboration and preliminary validation of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire, a 13-country EULAR initiative. Ann Rheum Dis 73(6):1012\u20131019. https:\/\/doi.org\/10.1136\/annrheumdis-2014-205207","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"6077_CR31","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1080\/1744666X.2020.1724090","volume":"16","author":"LM Perez-Chada","year":"2020","unstructured":"Perez-Chada LM, Balak D, Cohen JM, Ogdie A, Merola JF, Gottlieb AB (2020) Measurement properties of instruments assessing psoriatic arthritis symptoms for psoriasis clinical trials: a systematic literature review. Expert Rev Clin Immunol 16(3):267\u2013283. https:\/\/doi.org\/10.1080\/1744666X.2020.1724090","journal-title":"Expert Rev Clin Immunol"},{"issue":"11","key":"6077_CR32","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.3899\/jrheum.080182","volume":"35","author":"T Pincus","year":"2008","unstructured":"Pincus T, Swearingen CJ, Bergman M, Yazici Y (2008) RAPID3 (Routine Assessment of Patient Index Data 3), a rheumatoid arthritis index without formal joint counts for routine care: proposed severity categories compared to disease activity score and clinical disease activity index categories. J Rheumatol 35(11):2136\u20132147. https:\/\/doi.org\/10.3899\/jrheum.080182","journal-title":"J Rheumatol"},{"issue":"3","key":"6077_CR33","first-page":"469","volume":"27","author":"GH Ibrahim","year":"2009","unstructured":"Ibrahim GH, Buch MH, Lawson C, Waxman R, Helliwell PS (2009) Evaluation of an existing screening tool for psoriatic arthritis in people with psoriasis and the development of a new instrument: the Psoriasis Epidemiology Screening Tool (PEST) questionnaire. Clin Exp Rheumatol 27(3):469\u2013474","journal-title":"Clin Exp Rheumatol"},{"issue":"10","key":"6077_CR34","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/nrrheum.2011.125","volume":"7","author":"CA Chang","year":"2011","unstructured":"Chang CA, Gottlieb AB, Lizzul PF (2011) Management of psoriatic arthritis from the view of the dermatologist. Nat Rev Rheumatol 7(10):588\u2013598. https:\/\/doi.org\/10.1038\/nrrheum.2011.125","journal-title":"Nat Rev Rheumatol"},{"key":"6077_CR35","doi-asserted-by":"publisher","unstructured":"Gladman DD, Antoni C, Mease P, Clegg DO, Nash P (2005) Psoriatic arthritis: epidemiology, clinical features, course, and outcome. Ann Rheum Dis 64 Suppl 2:ii14\u201317. https:\/\/doi.org\/10.1136\/ard.2004.032482.","DOI":"10.1136\/ard.2004.032482"},{"key":"6077_CR36","doi-asserted-by":"publisher","unstructured":"Gottlieb A, Korman NJ, Gordon KB, Feldman SR, Lebwohl M, Koo JY, et al. (2008) Guidelines of care for the management of psoriasis and psoriatic arthritis: section 2. Psoriatic arthritis: overview and guidelines of care for treatment with an emphasis on the biologics. J Am Acad Dermatol 58(5):851\u2013864. https:\/\/doi.org\/10.1016\/j.jaad.2008.02.040.","DOI":"10.1016\/j.jaad.2008.02.040"},{"issue":"4","key":"6077_CR37","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s40265-014-0191-y","volume":"74","author":"PJ Mease","year":"2014","unstructured":"Mease PJ, Armstrong AW (2014) Managing patients with psoriatic disease: the diagnosis and pharmacologic treatment of psoriatic arthritis in patients with psoriasis. Drugs 74(4):423\u2013441. https:\/\/doi.org\/10.1007\/s40265-014-0191-y","journal-title":"Drugs"},{"issue":"3","key":"6077_CR38","doi-asserted-by":"publisher","first-page":"131","DOI":"10.5114\/reum.2017.68912","volume":"55","author":"P Sobolewski","year":"2017","unstructured":"Sobolewski P, Walecka I, Dopytalska K (2017) Nail involvement in psoriatic arthritis. Reumatologia 55(3):131\u2013135. https:\/\/doi.org\/10.5114\/reum.2017.68912","journal-title":"Reumatologia"},{"issue":"2","key":"6077_CR39","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1136\/ard.2003.018184","volume":"64","author":"JE Brockbank","year":"2005","unstructured":"Brockbank JE, Stein M, Schentag CT, Gladman DD (2005) Dactylitis in psoriatic arthritis: a marker for disease severity? Ann Rheum Dis 64(2):188\u2013190. https:\/\/doi.org\/10.1136\/ard.2003.018184","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"6077_CR40","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.semarthrit.2018.02.002","volume":"48","author":"GS Kaeley","year":"2018","unstructured":"Kaeley GS, Eder L, Aydin SZ, Gutierrez M, Bakewell C (2018) Dactylitis: a hallmark of psoriatic arthritis. Semin Arthritis Rheum 48(2):263\u2013273. https:\/\/doi.org\/10.1016\/j.semarthrit.2018.02.002","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"6077_CR41","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.semarthrit.2017.12.008","volume":"48","author":"GS Kaeley","year":"2018","unstructured":"Kaeley GS, Eder L, Aydin SZ, Gutierrez M, Bakewell C (2018) Enthesitis: a hallmark of psoriatic arthritis. Semin Arthritis Rheum 48(1):35\u201343. https:\/\/doi.org\/10.1016\/j.semarthrit.2017.12.008","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"6077_CR42","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s40744-016-0029-z","volume":"3","author":"A Kavanaugh","year":"2016","unstructured":"Kavanaugh A, Helliwell P, Ritchlin CT (2016) Psoriatic arthritis and burden of disease: patient perspectives from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis (MAPP) Survey. Rheumatol Ther 3(1):91\u2013102. https:\/\/doi.org\/10.1007\/s40744-016-0029-z","journal-title":"Rheumatol Ther"},{"issue":"5 Suppl 93","key":"6077_CR43","first-page":"S31","volume":"33","author":"X Baraliakos","year":"2015","unstructured":"Baraliakos X, Coates LC, Braun J (2015) The involvement of the spine in psoriatic arthritis. Clin Exp Rheumatol 33(5 Suppl 93):S31-35","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"6077_CR44","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/s41584-018-0006-8","volume":"14","author":"J Feld","year":"2018","unstructured":"Feld J, Chandran V, Haroon N, Inman R, Gladman D (2018) Axial disease in psoriatic arthritis and ankylosing spondylitis: a critical comparison. Nat Rev Rheumatol 14(6):363\u2013371. https:\/\/doi.org\/10.1038\/s41584-018-0006-8","journal-title":"Nat Rev Rheumatol"},{"issue":"5","key":"6077_CR45","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1136\/ard.2008.089367","volume":"68","author":"V Chandran","year":"2009","unstructured":"Chandran V, Schentag CT, Brockbank JE, Pellett FJ, Shanmugarajah S, Toloza SM et al (2009) Familial aggregation of psoriatic arthritis. Ann Rheum Dis 68(5):664\u2013667. https:\/\/doi.org\/10.1136\/ard.2008.089367","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"6077_CR46","first-page":"4","volume":"30","author":"DD Gladman","year":"2003","unstructured":"Gladman DD, Farewell VT (2003) HLA studies in psoriatic arthritis: current situation and future needs. J Rheumatol 30(1):4\u20136","journal-title":"J Rheumatol"},{"issue":"7","key":"6077_CR47","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1001\/archdermatol.2010.136","volume":"146","author":"A Ogdie","year":"2010","unstructured":"Ogdie A, Gelfand JM (2010) Identification of risk factors for psoriatic arthritis: scientific opportunity meets clinical need. Arch Dermatol 146(7):785\u2013788. https:\/\/doi.org\/10.1001\/archdermatol.2010.136","journal-title":"Arch Dermatol"},{"issue":"5","key":"6077_CR48","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.jaad.2014.12.008","volume":"72","author":"JM Cohen","year":"2015","unstructured":"Cohen JM, Husni ME, Qureshi AA, Merola JF (2015) Psoriatic arthritis: it\u2019s as easy as \u201cPSA.\u201d J Am Acad Dermatol 72(5):905\u2013906. https:\/\/doi.org\/10.1016\/j.jaad.2014.12.008","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"6077_CR49","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1093\/rheumatology\/kew410","volume":"56","author":"MC Karreman","year":"2017","unstructured":"Karreman MC, Weel A, van der Ven M, Vis M, Tchetverikov I, Nijsten TEC et al (2017) Performance of screening tools for psoriatic arthritis: a cross-sectional study in primary care. Rheumatology (Oxford) 56(4):597\u2013602. https:\/\/doi.org\/10.1093\/rheumatology\/kew410","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"6077_CR50","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s12955-020-01422-z","volume":"18","author":"LC Coates","year":"2020","unstructured":"Coates LC, Orbai AM, Azevedo VF, Cappelleri JC, Steinberg K, Lippe R et al (2020) Results of a global, patient-based survey assessing the impact of psoriatic arthritis discussed in the context of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire. Health Qual Life Outcomes 18(1):173. https:\/\/doi.org\/10.1186\/s12955-020-01422-z","journal-title":"Health Qual Life Outcomes"},{"issue":"5","key":"6077_CR51","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1080\/1744666X.2018.1468252","volume":"14","author":"T Gudu","year":"2018","unstructured":"Gudu T, Gossec L (2018) Quality of life in psoriatic arthritis. Expert Rev Clin Immunol 14(5):405\u2013417. https:\/\/doi.org\/10.1080\/1744666X.2018.1468252","journal-title":"Expert Rev Clin Immunol"},{"issue":"9","key":"6077_CR52","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1136\/annrheumdis-2018-215003","volume":"78","author":"A Kavanaugh","year":"2019","unstructured":"Kavanaugh A, Gottlieb A, Morita A, Merola JF, Lin CY, Birt J et al (2019) The contribution of joint and skin improvements to the health-related quality of life of patients with psoriatic arthritis: a post hoc analysis of two randomised controlled studies. Ann Rheum Dis 78(9):1215\u20131219. https:\/\/doi.org\/10.1136\/annrheumdis-2018-215003","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"6077_CR53","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1093\/rheumatology\/ker365","volume":"51","author":"CF Rosen","year":"2012","unstructured":"Rosen CF, Mussani F, Chandran V, Eder L, Thavaneswaran A, Gladman DD (2012) Patients with psoriatic arthritis have worse quality of life than those with psoriasis alone. Rheumatology (Oxford) 51(3):571\u2013576. https:\/\/doi.org\/10.1093\/rheumatology\/ker365","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"6077_CR54","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s40744-020-00221-8","volume":"7","author":"W Tillett","year":"2020","unstructured":"Tillett W, Merola JF, Thaci D, Holdsworth E, Booth N, Lobosco LS et al (2020) Disease characteristics and the burden of joint and skin involvement amongst people with psoriatic arthritis: a population survey. Rheumatol Ther 7(3):617\u2013637. https:\/\/doi.org\/10.1007\/s40744-020-00221-8","journal-title":"Rheumatol Ther"},{"issue":"2","key":"6077_CR55","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1002\/1529-0131(200104)45:2<151::AID-ANR168>3.0.CO;2-T","volume":"45","author":"JA Husted","year":"2001","unstructured":"Husted JA, Gladman DD, Farewell VT, Cook RJ (2001) Health-related quality of life of patients with psoriatic arthritis: a comparison with patients with rheumatoid arthritis. Arthritis Rheum 45(2):151\u2013158. https:\/\/doi.org\/10.1002\/1529-0131(200104)45:2%3c151::AID-ANR168%3e3.0.CO;2-T","journal-title":"Arthritis Rheum"},{"key":"6077_CR56","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1477-7525-7-25","volume":"7","author":"F Salaffi","year":"2009","unstructured":"Salaffi F, Carotti M, Gasparini S, Intorcia M, Grassi W (2009) The health-related quality of life in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis: a comparison with a selected sample of healthy people. Health Qual Life Outcomes 7:25. https:\/\/doi.org\/10.1186\/1477-7525-7-25","journal-title":"Health Qual Life Outcomes"},{"issue":"1","key":"6077_CR57","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2018-000867","volume":"5","author":"PJ Mease","year":"2019","unstructured":"Mease PJ, Etzel CJ, Huster WJ, Muram TM, Armstrong AW, Lisse JR et al (2019) Understanding the association between skin involvement and joint activity in patients with psoriatic arthritis: experience from the Corrona Registry. RMD Open 5(1):e000867. https:\/\/doi.org\/10.1136\/rmdopen-2018-000867","journal-title":"RMD Open"},{"issue":"1","key":"6077_CR58","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s40744-018-0135-1","volume":"6","author":"JF Merola","year":"2019","unstructured":"Merola JF, Shrom D, Eaton J, Dworkin C, Krebsbach C, Shah-Manek B et al (2019) Patient perspective on the burden of skin and joint symptoms of psoriatic arthritis: results of a multi-national patient survey. Rheumatol Ther 6(1):33\u201345. https:\/\/doi.org\/10.1007\/s40744-018-0135-1","journal-title":"Rheumatol Ther"},{"issue":"5","key":"6077_CR59","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.semarthrit.2017.09.002","volume":"47","author":"P Hojgaard","year":"2018","unstructured":"Hojgaard P, Klokker L, Orbai AM, Holmsted K, Bartels EM, Leung YY et al (2018) A systematic review of measurement properties of patient reported outcome measures in psoriatic arthritis: a GRAPPA-OMERACT initiative. Semin Arthritis Rheum 47(5):654\u2013665. https:\/\/doi.org\/10.1016\/j.semarthrit.2017.09.002","journal-title":"Semin Arthritis Rheum"},{"issue":"2","key":"6077_CR60","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.rdc.2016.01.002","volume":"42","author":"AM Orbai","year":"2016","unstructured":"Orbai AM, Ogdie A (2016) Patient-reported outcomes in psoriatic arthritis. Rheum Dis Clin North Am 42(2):265\u2013283. https:\/\/doi.org\/10.1016\/j.rdc.2016.01.002","journal-title":"Rheum Dis Clin North Am"},{"issue":"8","key":"6077_CR61","doi-asserted-by":"publisher","first-page":"990","DOI":"10.3899\/jrheum.181077","volume":"46","author":"AM Orbai","year":"2019","unstructured":"Orbai AM, Holland R, Leung YY, Tillett W, Goel N, Christensen R et al (2019) PsAID12 provisionally endorsed at OMERACT 2018 as core outcome measure to assess psoriatic arthritis-specific health-related quality of life in clinical trials. J Rheumatol 46(8):990\u2013995. https:\/\/doi.org\/10.3899\/jrheum.181077","journal-title":"J Rheumatol"},{"issue":"2","key":"6077_CR62","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/acr.20066","volume":"62","author":"T Pincus","year":"2010","unstructured":"Pincus T, Swearingen CJ, Bergman MJ, Colglazier CL, Kaell AT, Kunath AM et al (2010) RAPID3 (Routine Assessment of Patient Index Data) on an MDHAQ (Multidimensional Health Assessment Questionnaire): agreement with DAS28 (Disease Activity Score) and CDAI (Clinical Disease Activity Index) activity categories, scored in five versus more than ninety seconds. Arthritis Care Res (Hoboken) 62(2):181\u2013189. https:\/\/doi.org\/10.1002\/acr.20066","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"6077_CR63","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1477-7525-1-20","volume":"1","author":"B Bruce","year":"2003","unstructured":"Bruce B, Fries JF (2003) The Stanford Health Assessment Questionnaire: dimensions and practical applications. Health Qual Life Outcomes 1:20. https:\/\/doi.org\/10.1186\/1477-7525-1-20","journal-title":"Health Qual Life Outcomes"},{"issue":"5","key":"6077_CR64","first-page":"789","volume":"9","author":"JF Fries","year":"1982","unstructured":"Fries JF, Spitz PW, Young DY (1982) The dimensions of health outcomes: the health assessment questionnaire, disability and pain scales. J Rheumatol 9(5):789\u2013793","journal-title":"J Rheumatol"},{"issue":"4","key":"6077_CR65","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0123582","volume":"10","author":"B Michelsen","year":"2015","unstructured":"Michelsen B, Fiane R, Diamantopoulos AP, Soldal DM, Hansen IJ, Sokka T et al (2015) A comparison of disease burden in rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis. PLoS ONE 10(4):e0123582. https:\/\/doi.org\/10.1371\/journal.pone.0123582","journal-title":"PLoS ONE"},{"key":"6077_CR66","doi-asserted-by":"publisher","first-page":"563","DOI":"10.2147\/CCID.S90270","volume":"8","author":"B Truong","year":"2015","unstructured":"Truong B, Rich-Garg N, Ehst BD, Deodhar AA, Ku JH, Vakil-Gilani K et al (2015) Demographics, clinical disease characteristics, and quality of life in a large cohort of psoriasis patients with and without psoriatic arthritis. Clin Cosmet Investig Dermatol 8:563\u2013569. https:\/\/doi.org\/10.2147\/CCID.S90270","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"8","key":"6077_CR67","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1002\/acr.23460","volume":"70","author":"LC Coates","year":"2018","unstructured":"Coates LC, Tillett W, Shaddick G, Pincus T, Kavanaugh A, Helliwell PS (2018) Value of the Routine Assessment of Patient Index Data 3 in patients with psoriatic arthritis: results from a tight-control clinical trial and an observational cohort. Arthritis Care Res (Hoboken) 70(8):1198\u20131205. https:\/\/doi.org\/10.1002\/acr.23460","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"6077_CR68","doi-asserted-by":"publisher","unstructured":"Pincus T, Yazici Y, Bergman MJ (2009) RAPID3, an index to assess and monitor patients with rheumatoid arthritis, without formal joint counts: similar results to DAS28 and CDAI in clinical trials and clinical care. Rheum Dis Clin North Am 35(4):773\u2013778, viii. https:\/\/doi.org\/10.1016\/j.rdc.2009.10.008.","DOI":"10.1016\/j.rdc.2009.10.008"},{"issue":"9","key":"6077_CR69","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1007\/s00403-018-1855-3","volume":"310","author":"LM Perez-Chada","year":"2018","unstructured":"Perez-Chada LM, Cohen JM, Gottlieb AB, Duffin KC, Garg A, Latella J et al (2018) Achieving international consensus on the assessment of psoriatic arthritis in psoriasis clinical trials: an International Dermatology Outcome Measures (IDEOM) initiative. Arch Dermatol Res 310(9):701\u2013710. https:\/\/doi.org\/10.1007\/s00403-018-1855-3","journal-title":"Arch Dermatol Res"},{"issue":"3","key":"6077_CR70","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3899\/jrheum.160924","volume":"44","author":"M Di Carlo","year":"2017","unstructured":"Di Carlo M, Becciolini A, Lato V, Crotti C, Favalli EG, Salaffi F (2017) The 12-item Psoriatic Arthritis Impact of Disease Questionnaire: construct validity, reliability, and interpretability in a clinical setting. J Rheumatol 44(3):279\u2013285. https:\/\/doi.org\/10.3899\/jrheum.160924","journal-title":"J Rheumatol"},{"issue":"4","key":"6077_CR71","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1007\/s10067-019-04426-3","volume":"38","author":"U Kalyoncu","year":"2019","unstructured":"Kalyoncu U, Kiraz S, Bilgen SA, Karadag O, Akdogan A, Kilic L et al (2019) Change in PsAID-12 scores in patients continuing or discontinuing anti-TNF treatments in psoriatic arthritis: results from the HUR-BIO biologic registry. Clin Rheumatol 38(4):1187\u20131192. https:\/\/doi.org\/10.1007\/s10067-019-04426-3","journal-title":"Clin Rheumatol"},{"issue":"1","key":"6077_CR72","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13075-017-1277-1","volume":"19","author":"R Queiro","year":"2017","unstructured":"Queiro R, Canete JD, Montilla C, Abad M, Montoro M, Gomez S et al (2017) Minimal disease activity and impact of disease in psoriatic arthritis: a Spanish cross-sectional multicenter study. Arthritis Res Ther 19(1):72. https:\/\/doi.org\/10.1186\/s13075-017-1277-1","journal-title":"Arthritis Res Ther"},{"key":"6077_CR73","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.190219","author":"JA Walsh","year":"2019","unstructured":"Walsh JA, Wan MT, Willinger C, Husni ME, Scher JU, Reddy SM et al (2019) Measuring outcomes in psoriatic arthritis: comparing Routine Assessment of Patient Index Data (RAPID3) and Psoriatic Arthritis Impact of Disease (PSAID). J Rheumatol. https:\/\/doi.org\/10.3899\/jrheum.190219","journal-title":"J Rheumatol"},{"issue":"5 Suppl 39","key":"6077_CR74","first-page":"S14","volume":"23","author":"B Bruce","year":"2005","unstructured":"Bruce B, Fries JF (2005) The Health Assessment Questionnaire (HAQ). Clin Exp Rheumatol 23(5 Suppl 39):S14-18","journal-title":"Clin Exp Rheumatol"},{"issue":"13","key":"6077_CR75","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1056\/NEJMoa1507247","volume":"374","author":"MC Genovese","year":"2016","unstructured":"Genovese MC, Kremer J, Zamani O, Ludivico C, Krogulec M, Xie L et al (2016) Baricitinib in patients with refractory rheumatoid arthritis. N Engl J Med 374(13):1243\u20131252. https:\/\/doi.org\/10.1056\/NEJMoa1507247","journal-title":"N Engl J Med"},{"issue":"8","key":"6077_CR76","first-page":"821","volume":"14","author":"AB Gottlieb","year":"2015","unstructured":"Gottlieb AB, Langley RG, Philipp S, Sigurgeirsson B, Blauvelt A, Martin R et al (2015) Secukinumab improves physical function in subjects with plaque psoriasis and psoriatic arthritis: results from two randomized, phase 3 trials. J Drugs Dermatol 14(8):821\u2013833","journal-title":"J Drugs Dermatol"},{"issue":"11","key":"6077_CR77","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.3899\/jrheum.180792","volume":"46","author":"IB McInnes","year":"2019","unstructured":"McInnes IB, Puig L, Gottlieb AB, Ritchlin CT, Song M, You Y et al (2019) Association between enthesitis and health-related quality of life in psoriatic arthritis in biologic-naive patients from 2 phase III ustekinumab trials. J Rheumatol 46(11):1458\u20131461. https:\/\/doi.org\/10.3899\/jrheum.180792","journal-title":"J Rheumatol"},{"issue":"8","key":"6077_CR78","first-page":"1910","volume":"28","author":"P Davis","year":"2001","unstructured":"Davis P, Howard R, Brockway P (2001) An evaluation of telehealth in the provision of rheumatologic consults to a remote area. J Rheumatol 28(8):1910\u20131913","journal-title":"J Rheumatol"},{"issue":"4","key":"6077_CR79","doi-asserted-by":"publisher","first-page":"415","DOI":"10.3402\/ijch.v63i4.17758","volume":"63","author":"M Jong","year":"2004","unstructured":"Jong M, Kraishi M (2004) A comparative study on the utility of telehealth in the provision of rheumatology services to rural and northern communities. Int J Circumpolar Health 63(4):415\u2013421. https:\/\/doi.org\/10.3402\/ijch.v63i4.17758","journal-title":"Int J Circumpolar Health"},{"key":"6077_CR80","unstructured":"American College of Rheumatology (2020) Guiding principles from the American College of Rheumatology for decision making around in person urgent versus virtual non urgent medical care. https:\/\/www.rheumatology.org\/Portals\/0\/Files\/Guiding-Principles-Urgent-vs-Non-Urgent-Services.pdf. Accessed September 1, 2020"},{"key":"6077_CR81","unstructured":"American Telemedicine Association (2020) ATA\u2019s quick-start guide to telehealth during a health crisis. https:\/\/cdn2.hubspot.net\/hubfs\/5096139\/Files\/Resources\/ATA_QuickStart_Guide_to_Telehealth_4-10-20.pdf. Accessed April 10, 2020"},{"key":"6077_CR82","unstructured":"Alliance for Connected Care (2020) State telehealth and licensure expansion COVID-19 dashboard - alliance for connected care. http:\/\/connectwithcare.org\/state-telehealth-and-licensure-expansion-covid-19-chart\/. Accessed 10 Apr\u00a02020"},{"key":"6077_CR83","unstructured":"Center for Connected Health Policy (2020) COVID-19 related state actions https:\/\/www.cchpca.org\/covid-19-related-state-actions. Accessed April 10, 2020"},{"issue":"10","key":"6077_CR84","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1002\/acr.22853","volume":"68","author":"IM Ward","year":"2016","unstructured":"Ward IM, Schmidt TW, Lappan C, Battafarano DF (2016) How critical is tele-medicine to the rheumatology workforce? Arthritis Care Res (Hoboken) 68(10):1387\u20131389. https:\/\/doi.org\/10.1002\/acr.22853","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"4","key":"6077_CR85","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1002\/acr.23518","volume":"70","author":"DF Battafarano","year":"2018","unstructured":"Battafarano DF, Ditmyer M, Bolster MB, Fitzgerald JD, Deal C, Bass AR et al (2018) 2015 American College of Rheumatology workforce study: supply and demand projections of adult rheumatology workforce, 2015\u20132030. Arthritis Care Res (Hoboken) 70(4):617\u2013626. https:\/\/doi.org\/10.1002\/acr.23518","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"6077_CR86","doi-asserted-by":"publisher","unstructured":"Kichloo A, Albosta M, Dettloff K, Wani F, El-Amir Z, Singh J, et al. (2020) Telemedicine, the current COVID-19 pandemic and the future: a narrative review and perspectives moving forward in the USA. Fam Med Community Health 8(3). https:\/\/doi.org\/10.1136\/fmch-2020-000530.","DOI":"10.1136\/fmch-2020-000530"},{"key":"6077_CR87","doi-asserted-by":"publisher","unstructured":"Gossec L, Cantagrel A, Soubrier M, Berthelot JM, Joubert JM, Combe B, et al. (2018) An e-health interactive self-assessment website (Sanoia\u00ae) in rheumatoid arthritis. A 12-month randomized controlled trial in 320 patients. Joint Bone Spine 85(6):709\u2013714. https:\/\/doi.org\/10.1016\/j.jbspin.2017.11.015.","DOI":"10.1016\/j.jbspin.2017.11.015"},{"issue":"5","key":"6077_CR88","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/j.clinthera.2017.03.018","volume":"39","author":"IB Hirsch","year":"2017","unstructured":"Hirsch IB, Martinez J, Dorsey ER, Finken G, Fleming A, Gropp C et al (2017) Incorporating site-less clinical trials into drug development: a framework for action. Clin Ther 39(5):1064\u20131076. https:\/\/doi.org\/10.1016\/j.clinthera.2017.03.018","journal-title":"Clin Ther"},{"key":"6077_CR89","doi-asserted-by":"publisher","unstructured":"Laggis CW, Williams VL, Yang X, Kovarik CL (2019) Research techniques made simple: teledermatology in clinical trials. J Invest Dermatol 139(8):1626\u20131633 e1621. https:\/\/doi.org\/10.1016\/j.jid.2019.04.004.","DOI":"10.1016\/j.jid.2019.04.004"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-022-06077-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-022-06077-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-022-06077-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,30]],"date-time":"2022-04-30T11:05:59Z","timestamp":1651316759000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-022-06077-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,26]]},"references-count":89,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["6077"],"URL":"https:\/\/doi.org\/10.1007\/s10067-022-06077-3","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,26]]},"assertion":[{"value":"18 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The manuscript does not contain clinical studies or patient data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"This manuscript did not include participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"This manuscript did not include participants.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"A. B. Gottlieb has received honoraria as an advisory board member and consultant for Anaptyps Bio, Avotres Therapeutics, Boehringer Ingelheim, Bristol Myers Squibb, Dermavant, Incyte, GlaxoSmithKline, Janssen, LEO Pharma, Eli Lilly, Novartis, Pfizer, Sun Pharmaceutical, UCB, and XBiotech and has received research\/educational grants from Boehringer Ingelheim, Incyte, Janssen, Novartis, Sun Pharmaceutical, UCB, and XBiotech. A. F. Wells has received honoraria as an advisory board member and consultant for AbbVie, Amgen, Bristol Myers Squibb, Lilly, Novartis, Pfizer, and Sanofi. J. F. Merola is a consultant and\/or investigator for Merck, Bristol Myers Squibb, AbbVie, Dermavant, Eli Lilly, Novartis, Janssen, UCB, Sanofi, Regeneron, Arena, Sun Pharma, Biogen, Pfizer, EMD Sorono, Avotres, and LEO Pharma.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}